Clinical Trial Update: A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028) [Phase 2]

View source ↗

Summary

Phase 2 trial update for vaniprevir (MK-7009) in chronic hepatitis C patients who previously participated in other vaniprevir studies; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• vaniprevir (vaniprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2014-09-29